Literature DB >> 22965239

A systematic review of antibiotic use and infection in breast reconstruction: what is the evidence?

Brett T Phillips1, Muath Bishawi, Alexander B Dagum, Sami U Khan, Duc T Bui.   

Abstract

BACKGROUND: The literature reports overall complication rates in breast reconstruction to be as high as 60 percent. Infection rates can exceed 20 percent, much higher than anticipated in clean elective surgery. There is no consensus among surgeons regarding the necessary duration of antibiotic prophylaxis, although the Centers for Disease Control and Prevention guidelines suggest only 24 hours. This systematic review examines antibiotic regimens and associated infection rates in breast reconstruction.
METHODS: Systematic electronic searches were performed in the PubMed, Ovid, and Cochrane databases using Medical Subject Headings terms for studies reporting antibiotic use and infection in all forms of breast reconstruction. Studies between 1970 and 2011 were reviewed. Included publications were required to report an antibiotic protocol and infection rate.
RESULTS: A total of 834 abstracts were identified, 81 of which met inclusion criteria and were included in the review. The overall reported infection rates in the included studies varied between 0 and 29 percent (average, 5.8 percent). When comparing combined patient cohorts receiving no antibiotics, less than 24 hours, and greater than 24 hours, the average infection rates were 14.4, 5.8, and 5.8 percent, respectively.
CONCLUSIONS: There is no consensus on the necessary duration of antibiotic prophylaxis following breast reconstruction. No benefit was found in patients who received more than 24 hours of postoperative antibiotics. Standardized definitions for antibiotic regimens, unit of analysis reporting, and a new breast reconstruction surgical-site infection grading system are offered to improve standardized outcome documentation. Randomized controlled trials are warranted to best determine an optimal antibiotic regimen. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

Entities:  

Mesh:

Year:  2013        PMID: 22965239     DOI: 10.1097/PRS.0b013e3182729c39

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  29 in total

Review 1.  Breast Reconstruction Following Cancer Treatment.

Authors:  Bernd Gerber; Mario Marx; Michael Untch; Andree Faridi
Journal:  Dtsch Arztebl Int       Date:  2015-08-31       Impact factor: 5.594

2.  Antibiotic Prophylaxis in Alloplastic Breast Reconstruction: Regimens and Outcomes.

Authors:  Edward H Liu; Mary Tong; Grace Y Kim; Forough Farrokhyar; Arianna Dal Cin
Journal:  Plast Surg (Oakv)       Date:  2021-05-19       Impact factor: 0.947

3.  Review of Early Signs of Breast Implant Infection.

Authors:  Ruixue Zhang; Dylan Singh; Fereydoun D Parsa
Journal:  Aesthetic Plast Surg       Date:  2022-01-29       Impact factor: 2.326

4.  Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients.

Authors:  Ramona Barbieri; Marianna Pesce; Simonetta Franchelli; Ilaria Baldelli; Andrea De Maria; Anna Marchese
Journal:  BMC Microbiol       Date:  2015-02-10       Impact factor: 3.605

5.  Acellular Dermal Matrix in Reconstructive Breast Surgery: Survey of Current Practice among Plastic Surgeons.

Authors:  Ahmed M S Ibrahim; Pieter G L Koolen; Azra A Ashraf; Kuylhee Kim; Marc A M Mureau; Bernard T Lee; Samuel J Lin
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-05-07

6.  A systematic review of infection rates and associated antibiotic duration in acellular dermal matrix breast reconstruction.

Authors:  Brett T Phillips; Muath Bishawi; Alexander B Dagum; Duc T Bui; Sami U Khan
Journal:  Eplasty       Date:  2014-11-11

7.  Salvaging the Infected Breast Tissue Expander: A Standardized Multidisciplinary Approach.

Authors:  George M Viola; Jesse C Selber; Melissa Crosby; Issam I Raad; Charles E Butler; Mark T Villa; Steven J Kronowitz; Mark W Clemens; Patrick Garvey; Wei Yang; Donald P Baumann
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-06-10

8.  Is antibiotic prophylaxis in breast augmentation necessary? A prospective study.

Authors:  E Keramidas; N S Lymperopoulos; S Rodopoulou
Journal:  Plast Surg (Oakv)       Date:  2016-08-19       Impact factor: 0.947

9.  Improving Antimicrobial Regimens for the Treatment of Breast Tissue Expander-Related Infections.

Authors:  George M Viola; Donald P Baumann; Kriti Mohan; Jesse Selber; Patrick Garvey; Gregory Reece; Issam I Raad; Kenneth V Rolston; Melissa A Crosby
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-05-06

10.  Prosthetic Breast Reconstruction With Acellular Dermal Matrices: Achieving Predictability and Reproducibility.

Authors:  Maurice Y Nahabedian
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.